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Introduction
Surgical management of cholesteatoma is still a controversial issue. Classic concepts are based on microscopic surgical management, as is the traditional classification of open tympanoplasties-canal wall down (CWD) and closed tympanoplasties-canal wall up (CWU), depending on the preservation of the posterior ear canal wall. The choice between these two techniques is based on a number of factors, although in most cases, the main factors influencing the definitive attitude toward surgical management of cholesteatoma are experience, personal beliefs and confidence of each surgeon with each technique. Starting in the 1990s, operative endoscopy was introduced in otologic surgery 1 , and significantly changed not only surgical concepts 2 but also anatomic and physiologic concepts 3 , and has become increasingly popular during the last 15 years. Since the introduction of this instrument, the concept of a minimally invasive approach in middle ear surgery is changing. Endoscopic middle ear surgery can offer some advantages compared to the traditional microscopic technique, guaranteeing excellent visualization of mesotympanic structures and direct visual control of hidden areas such as anterior epitympanic spaces, retrotympanum and protympanum. Nonetheless, when a new technique is introduced, evaluation of results is essential to its acceptance by the scientific community. The aim of present paper was to perform a systematic literature review, which may help to better understand the results associated with endoscopic techniques (both used exclusively and in combination with microscopic approaches) in treatment of cholestetoma.
Materials and methods

Search strategy
This systematic review sought to answer the question: is endoscopic ear surgery effective in treatment of middle ear cholesteatoma? A structured search of the literature was performed on PUBMED with the following search terms: "middle ear cholesteatoma" and "endoscopic ear surgery". After running the above-search terms, abstracts and titles were obtained. The titles and abstracts of the search results were screened and articles eligible for further review were identified. Inclusion criteria for abstracts were:
• article describing the results of endoscopic ear surgery (alone or in association with the operating microscope) for treatment of middle ear cholesteatoma; • English language; • original papers. Exclusion criteria for abstracts were:
• clearly unrelated pathologies of the ear; • no original analysis (e.g. reviews) or animal or other basic science laboratory studies. The full texts of the articles identified were obtained for a second screening, in order to select studies for inclusion.
Inclusion criteria for full-text articles identified were:
• diagnosis of middle ear cholesteatoma; • use of endoscopic middle ear surgery alone or combined with microscopic techniques; Exclusion criteria for full-text articles identified were:
• lack of definitive diagnosis of cholesteatoma;
• lack of sufficient clinical data; • redundant cohorts of patients that were already reported by the same authors. A further manual check was performed on the references included within articles. The final number of articles included in the present review was identified, and the main information was extracted and summarized.
Results
Running the above-search string in PubMed, 72 articles were identified. After an initial check, full-text retrieval and manual cross-checking of references included within the articles, 7 studies, published between 2002 and 2013 (comprising a total of 515 patients and 517 surgeries overall) clearly met inclusion criteria and were chosen for the analysis (Table I ). All articles analyzed only patients suffering from middle ear cholesteatoma with no history of previous ear surgeries. The disease status at last control was available in all patients, and the mean follow time was 23.4 months (range, 11-43 months). Analyzing the articles chosen for our review, it can be noted that three authors (Tarabichi, Migirov and Barakate) exclusively performed transcanal endoscopic surgeries, while in the other five reports a combined technique was also applied if necessary. 
Discussion
The exposure and visualization of the entire middle ear space are sometimes difficult using only microscopic vision. With recent advances in minimally-invasive surgery, the use of the endoscope has led to new treatment options for middle ear pathologies 4 5 . Moreover, the anatomy of the middle ear is particularly complex and an endoscopic approach represents an improvement with regard to the anatomic concepts of this region because it guarantees round-the-corner views of hidden areas such as the sinus tympani, facial recess, anterior epitympanic spaces, attic, hypotympanum and protympanum 6 . Cholesteatoma surgery primarily aims to eradicate the disease process and provide the patient with a safe and dry ear. The main problems regarding attic cholesteatoma removal are residual and recurrence. The former is due to insufficient primary resection of the epidermal matrix, and classically presents a pearl-like aspect. Insufficient resection may be due a very fine epidermal matrix or middle-ear inflammation, in addition to limited exposition of hidden areas such as the epitympanic space and sovratubal recess. Actually, the view during microscopic surgery is defined and limited by the narrowest segment of the ear canal; this basic limitation has forced surgeons to create a parallel port through the mastoid to gain keyhole access to the attic. Despite the illumination and magnification offered by the operating microscope, it has distinct limitations. The persistence of physiopathologic phenomena that determined cholesteatoma development, presents as a new attic retraction that requires a further surgical approach to avoid the reformation of attic cholesteatoma. Recurrence consists in a new, dangerous tympanic retraction pocket caused by inadequate reconstruction of the scutum and tympanic loss of substance inducing persistence of the physiopathologic process of middle-ear depression. While recurrence can be diagnosed otoscopically, residual cholesteatoma is classically independent of the eardrum and only surgical revision can determine definite diagnosis; this is the rationale of second look procedures, in addition to functional issues. This review focuses on surgical improvements related to the mini-invasive treatment of middle ear cholesteatoma. At the moment, the main treatment options for this pathology are two basic, well-standardized microscopic surgical procedures: canal wall-down (CWD) and the canal wallup (CWU) mastoidectomy with tympanoplasty. Both these traditional approaches to the attic have mainly provided limited access through postauricular mastoidectomy, with many surgeons using the ear canal to access the anterior part of the attic 7 . The intact canal wall approach has traditionally been favoured for its simpler postoperative care and maintenance 8 . Moreover, by preserving the anatomy of the middle ear, the cavity is permitted to get wet and, thereby, does not limit patients in future activities 9 . However, many surgeons have noted high rates of recurrent and residual disease using this approach, and thus advocate a staged or 'second-look' procedure that occurs months to years after the first 10 11 . Because of these disadvantages, others prefer to remove the posterior canal in their treatment of cholesteatoma 12 13 . This group conjectures that improved visualization of the disease and affected middle ear anatomy, including the sinus tympani and anterior attic that are the most frequent sites of residual cholesteatoma in traditional intact canal wall surgery 14 15 , result in greater long-term disease-free states. Although open tympanoplasty decreases the rate of recurrence, nevertheless, in our opinion, the removal of the posterior canal does not always ensure complete visualization of sinus tympani that often remain hidden from surgical view. This situation may strongly be connected with the high rate of residual disease observed after this procedure. These observations suggest that there is no single procedure to treat all cases of cholesteatoma, and that the otologic surgeon should be flexible in chosing a procedure depending on the individual case. Literature data show that recurrent cholesteatoma is still observed in nearly 20% of CWU tympanoplasties, with an overall relapse rate of up to 70%, while open techniques are often accredited with a rate of residual disease of less than 7% and nearly no recurrent disease 16. Gaillardin et al. 17 after a mean follow-up of 48 months (range, 24-96 months) found a rate of residual disease of 25% considering cholesteatomas in 113 ears operated with a closed canal wall-up tympanoplasty. Mishiro et al. 18 described recurrent cholesteatoma in 19.4% of ears treated with closed tympanoplasty. Haginomori et al. 19 performed 85 canal wall-down tympanoplasties and observed 18 (21%) residual cholesteatomas after 1 year at second-look. Over a follow-up period ranging from 4 to 15 years (mean follow-up, 8 years), de Zinis et al. observed only 4 (2.1%) residual cholestatomas and no recurrent cholestatomas among 189 ears treated with CWD tympanoplasty for cholesteatoma of the middle ear. Nevertheless, 17 patients (9.0%) developed small keratin pearls, while recurrent otorrhoea and mastoid cavity granulation tissue formation occurred in 10 cases (5.2%). Sanna et al. 20 evaluated 222 cases of cholesteatomas operated with their modified Bondy's technique: they reported a pearl-like residual cholesteatoma in 7.4% of ears, while no recurrence was discovered over a mean follow-up of 7.8 years (range, 5-16 years). In their meta-analysis performed on 13 studies including a total of 4720 patients, Tomlin et al. 21 demonstrated that, when realized as a single-stage surgery, an intact canal wall approach to cholesteatoma treatment has nearly 3 times greater likelihood of recurrence than a canal wall down surgery. In general, only 2 of the studies reported no significant differences between the two techniques, while 11 of the 13 data sets statistically favoured the canal wall down approach. However, the rate of cholesteatoma recurrence depends not only on the follow-up period, surgical methods and surgical techniques, but also in the methods used for statistical analysis. For this reason, Mishiro et al. 18 analyzed the recurrence rate of cholesteatoma after 345 interventions of tympanoplasty (n = 113, CWD; n = 232, CWU) using Kaplan-Meir survival analysis. After a mean follow-up period of 5 years, the recurrence rate (comprising residual and recurrent cholesteatomas) was 11.8% although the authors underlined how the follow-up rates of patients decreased during the time after surgery (93.3% after 1 years, 78.3% after 3 years, 70.1% after 5 years). In our opinion, this observation represents an important point of view that authors should always keep in mind to obtain a more correct analysis of surgical outcomes. In fact, the data of many reports may be affected/altered by the number of patients who dropped out from clinical follow-up. Regarding the data in our review, the high rate of exclusive endoscopical transcanal procedures performed (57%) should be noted in comparison of the lower rate of combined approaches requiring mastoidectomy (43%). Another point of interest is the rate of residual disease and recurrences that appear lower compared to data reported in the literature for canal wall up interventions performed exclusively by mean microscopy. These promising results seem to confirm the usefulness of the endoscope in terms of outcomes. The main limitations related to the seven studies analyzed in our review are the short time of follow-up and the limited number of patients treated by the authors. In fact, with the exception of Tarabichi et al. 7 there is no report showing a follow-up greater than three years, and only Marchioni et al. 22 reported a cohort larger than 100 patients. In general, both these issues are closely connected with the recent introduction of endoscopic middle ear surgery that needs more time to reach a sufficient number of cases and an adequate time of follow-up. Nevertheless, from studies analyzed in our review, the endoscope appears to allow an important reduction of unnecessary mastoidectomies in cases of cholesteatoma limited to the middle ear cavity, favouring the increase of exclusive transcanal middle ear surgeries. Moreover, in cases of pathologies involving the mastoid, endoscopic assistance may promote the choice of canal wall up procedures limiting the rate of recurrences and residual disease typically associated with this approach.
Conclusions
On the basis of literature data, canal wall down tympanoplasty still remains the most effective procedure in preventing recurrent disease after a single-stage surgery. Nevertheless, because the surgical approach depends on patient preference and lifestyle factors, the maintenance of posterior ear canal should be achieved in young patients, and the endoscopic technique may represent an important tool in obtaining this aim. Our review appears to confirm the importance of this tool in middle ear surgery. Obviously further reports are still needed to confirm and integrate this initial data, increasing the number of patients and organizing an accurate follow-up method to avoid the "drop out" issues.
